Make a Contribution

Your support is essential to our research effort. All contributions are appreciated. You can donate online below. A receipt will be mailed to you.

Donate

The McCusker Foundation for Alzheimers Disease Research

a world free of
Alzheimer’s disease

184 Hampden Rd,
Nedlands, WA 6009.
Telephone: (08) 9347 4200 Facsimile: (08) 9347 4299

Key Partners / Supporters

Research Publications

Reports

Newsletters

Research Publications

Barron A, Verdile G and Martins RN. Gonadotropins: potential targets for preventative and therapeutic interventions in Alzheimer’s disease. Future Medicine (2006) 1(2) 189-202.

Martins IJ, Hone E, Foster J, Sünram-Lea S, Gnjec A, Fuller SJ, Nolan D, Gandy, SE and Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease. Molecular Psychiatry (2006) 11, 721-736 (online)

Barron AM, Verdile G. and Martins RN. The role of gonadotropins in Alzheimer’s disease: potential neurodegenerative mechanisms. Endocrine (2006) (2):257-70.

Bates KA, Martins RN, and Harvey AR. Oxidative stress in a rat model of chronic gliosis. Neurobiol Aging. (2006) June 22(Epub ahead of print).

Burkhardt MS, Foster JK, Clarnette RM, Chub SAP, Bruce DG, Drummond PD, Martins RN and Yeap BB. Interaction between Testosterone and Apolipoprotein E e4 Status on Cognition in Healthy Older Men. The Journal of Endocrinology & Metabolism. (2006) 91(3):1168-1172.

House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R. Quantitative MR imagining R2 relaxometry in elderly participants reporting memory loss. American Journal Neuroradiology. (2006) (2):430-9.

Verdile G, Gandy SE, Martins RN. The role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid. Neurochem Res. (2006) Published online.

Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, Bickeboller H, Wagenpfeil S, Mueller J, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Muller U, Illig T, Heun R, Egensperger R, Schlegel J, Forstl H, Martins RN, Geman Sib-Pair Study Group, Kurz A. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer’s disease. Human Molecular Genetics (2006) (15) 2446-2456.

Barron AM, Fuller SJ, Verdile G, Martins RN. Reproductive hormones modulate oxidative Stress in Alzheimer’s disease. Antioxidant. Redox signal. (2006) Nov 8(11-12):2047-2059

Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IRA, Martins RN, Krok JBJ, Halliday GM, Kril J, Schofield PR, Mann DMA, Hutton M. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain (2006) 129: 3124-3126.

Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins RN, Reiss K, Darbvinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer’s type changes induced by Correlia spirochetes. Neurobiology of Aging 2006) 27: 228-236.

Flicker L, Martins RN, Thomas J, Psych JA, Taddei K, Vasikaran SD, Norman P, Jamrozik K, Almeida OP. B-vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging (2006) Nov. 17 [Epub ahead of print]

Butterfield, DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease: An Initial assessment. J Alzheimer’s Disease. 2006 10(4):391-7.

McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: A putative marker of an ongoing inflammatory process. Exp. Gerontology (2006) Nov. 29 [EPub ahead of print]